Nab-paclitaxel
(asked on 17th January 2023) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the breast cancer drug Abraxane will be made available on the NHS.
This question was answered on 23rd January 2023
Abraxane (nab-paclitaxel) is available to National Health Service patients for several indications including as a monotherapy or as part of combination chemotherapy for adjuvant, neoadjuvant and palliative indications in breast cancer in patients who are hypersensitive to paclitaxel or docetaxel or who are vulnerable to the side-effects of chemotherapy and require a reduction in the risks of treatment.